Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jun 26.
Published in final edited form as: Chemistry. 2019 May 27;25(36):8465–8470. doi: 10.1002/chem.201900430

15N MRI of SLIC-SABRE hyperpolarized 15N-labelled pyridine and nicotinamide

Alexandra Svyatova a,b, Ivan V Skovpin a,b, Nikita V Chukanov a,b, Kirill V Kovtunov a,b, Eduard Y Chekmenev c,d, Andrey N Pravdivtsev e, Jan-Bernd Hövener e, Igor V Koptyug a,b
PMCID: PMC6679352  NIHMSID: NIHMS1041568  PMID: 30950529

Abstract

Magnetic Resonance Imaging (MRI) is a powerful non-invasive diagnostic method extensively used in biomedical studies. A significant limitation of MRI is its relatively low signal-to-noise ratio, which can be increased by hyperpolarizing nuclear spins. One promising method is Signal Amplification By Reversible Exchange (SABRE), which employs parahydrogen as a source of hyperpolarization. Recent studies demonstrated the feasibility to improve MRI sensitivity with this hyperpolarization technique. Hyperpolarized 15N nuclei in biomolecules can potentially retain their spin alignment for tens of minutes, providing an extended time window for the utilization of the hyperpolarized compounds. In this work, we demonstrate for the first time that radio-frequency-based SABRE hyperpolarization techniques can be used to obtain 15N MRI of biomolecule 1-15N-nicotinamide. Two image acquisition strategies were utilized and compared: Single Point Imaging (SPI) and Fast Low Angle SHot (FLASH). These methods demonstrated opportunities of high-field SABRE for biomedical applications.

Keywords: SABRE, 15N MRI, parahydrogen, hyperpolarization, molecular imaging

Entry for the Table of Contents

15N Signal Amplification By Reversible Exchange hyperpolarization of biomolecules were carried out in situ in a MRI scanner. This allowed us to perform 15N MRI of 15N-pyridine and 1-15N-nicotinamide using two different pulse sequences: Single Point Imaging and Fast Low Angle SHot (FLASH). The demonstrated method is a promising approach for biomedical applications.

graphic file with name nihms-1041568-f0001.jpg


Signal Amplification By Reversible Exchange[1] (SABRE) is a rapidly developing parahydrogen-based hyperpolarization approach.[2] Although parahydrogen (pH2) itself is silent for Nuclear magnetic Resonance (NMR)), simultaneous exchange of pH2 and the substrate on an Ir-based organometallic complex provides polarization transfer from pH2–derived hydrides to the substrate, and results in an enhancement of the nuclear spin polarization (P) by several orders of magnitude.[37]

At first, SABRE was demonstrated using pyridine and nicotinamide as substrates.[1] SABRE was performed at magnetic fields of ≈10 mT simply by shaking a sample under pH2 atmosphere while the signal was acquired later at the high magnetic field of an NMR spectrometer (9.4 T). These simple “shake and run” experiments at low magnetic fields provided high enhancements of the 1H signal by a factor of 550 and 345 for pyridine and nicotinamide, respectively. In addition, 1H MRI of pyridine was obtained with balanced steady-state free precession[8] (b-SSFP) pulse sequence.

In another experiment, SABRE was used to continuously hyperpolarize substrates[9] at a low magnetic field (6.5 mT). This approach was used to enable MRI at Earth’s magnetic field. Continuous hyperpolarization[10] resolves the problem of short hyperpolarization lifetimes (T1-relaxation time is on the order of a few seconds for protons).

The hyperpolarization and imaging of substrates in situ, i.e. at the same, constant magnetic field, was shown as well.[11] This approach allowed to accelerate the imaging by shortening the repetition time from 8 s to 0.2 s and to increase the spatial resolution in a way that additional dynamic processes (e.g., pH2 flow motion) became observable.

Hyperpolarized protons have a relatively short T1, meanwhile, heteronuclei offer a significantly longer relaxation time. 15N T1 relaxation values of three to twenty minutes were reported.[1217] These comparatively long lifetimes significantly increase the time available for sample purification,[18,19] in vivo administration, distribution, metabolism and MRI. The first reports of 15N polarization by dissolution DNP[20] show a low efficiency of direct 15N polarization (P~ 4%) with super long build-up times about 2 hours.[13] However, low temperature cross-polarization to nitrogen-15 during dissolution DNP conditions[21] allows to achieve about 20% polarization for urea molecule with moderate build-up times (15 min).[22] Despite the high polarization level, the amount of polarized substance is extremely low (100μL, 0.8M) that along with long build-up times and high cost of DNP instrument limit possible utilization of DNP polarized substances for 15N MRI.

EXPERIMENTAL DESIGN

SABRE showed great potential for heteronuclear MRI: 13C,[1,7,23] 15N,[24] 19F[25,26] and 31P[27,28] images of SABRE polarized substrates were obtained. Here, we focused on 15N nucleus because it can be used in biomedical studies, for example, in pH sensing[24,29] or metabolic imaging.[3032]

Many SABRE studies were based on polarization transfer at microtesla magnetic fields. These fields are beneficial because polarization transfer to heteronuclei occurs spontaneously in strongly coupled spin systems. The approach based on the use of low magnetic fields was termed SABRE - Shield Enables Alignment Transfer to Heteronuclei (SABRE-SHEATH)[33,34] and more than 30% 15N-polarization was demonstrated.[18,34,35] However, this approach has two shortcomings:[24,33,3537] a need of fast magnetic field alteration and creation of polarizer with precise ultralow magnetic field.

In another approach, termed HF-SABRE, the spontaneous polarization transfer from pH2-derived hydrides to 15N nuclei and MR observation are carryied out in situ at a constant, high magnetic field (~10 T).[38] Here, pH2 is continuously bubbled through the sample, which is placed in the magnet of NMR or MRI, and spontaneous polarization transfer occurs while high-frequency electro-magnetic fields are played out. Although some shortcomings of SABRE-SHEATH were mitigated by HF-SABRE, the 15N-polarization enhancement factors were significantly lower than those provided by SABRE-SHEATH.[38,39]

A previous report on MRI of 15N HF-SABRE[40] revealed that HF-SABRE generates (a relatively low) anti-phase polarization, which is difficult to image due to partial signal cancelation. Therefore, HF-SABRE will likely be limited to in vitro imaging and the calibration of hardware or radio-frequency (RF) pulse sequences. Moreover, continuous pH2 bubbling was required to obtain 2D MRI with extensive signal averaging.

To improve the efficiency of SABRE polarization at high magnetic fields, several polarization transfer techniques employing RF irradiation were developed: Alternating Delays Achieve Polarization Transfer SABRE (ADAPT-SABRE),[41] SABRE Insensitive Nuclei Enhanced by Polarization Transfer (SABRE-INEPT),[42] Low Irradiation Generation of High-Tesla SABRE (LIGHT-SABRE),[43] adiabatic RF-SABRE,[44] Spin Lock Induced Crossing SABRE (SLIC-SABRE),[45] and Quasi-resonance SABRE (QUASR-SABRE).[46] Some of these approaches may deliver 15N HP comparable with the one achieved by SABRE-SHEATH,[46] and also mitigate SABRE-SHEATH shortcomings.

In this work, we present a strategy for performing imaging of SLIC-SABRE hyperpolarized compounds inside an MRI scanner for potential biomedical applications. SLIC-SABRE sequence is an improved version of LIGHT-SABRE where fast singlet – triplet mixing on the Ir-complex is taken into account that makes that variant more robust than LIGHT-SABRE. It was achieved by introduction of a 90o 1H-RF pulse before CW[45] (see Fig. 2,C and Fig. 3,C). Note, that by repeating the SLIC-SABRE block several times polarization is accumulated in the form of free substrate see (SI,Fig. S2, B).

Figure 2.

Figure 2.

15N single-point MRI of 0.1 M 15N-Py (A) and 0.1 M 15N-NA (B) in methanol-d4 with 5 mM Ir(COD)(IMes)Cl hyperpolarized by means of SLIC-SABRE with a 7 sccm pH2 flow rate at 9.4 T. 2D images were acquired using SLIC-SABRE hyperpolarization and SPI spatial encoding and acquisition elements (C). Total scan time was 5.5 min (A) and 27 min (B). The signal void (circle) corresponds to the pH2 supply capillary. Experiments were carried out at room temperature. The number of SLIC-SABRE cycles, n, was 1 for 15N-Py and 5 for 15N-NA. In both cases, k-space was acquired once, acquisition spectral width (SW) was 12 kHz, spatial resolution was 565×565 μm2/pixel. Field of view was 0.9×0.9 cm2, acquisition matrix was 16×16, It was zero-filled to 128×128 before the image reconstruction.

Figure 3.

Figure 3.

15N FLASH-MRI of 1 M 15N-Py with 50 mM of Ir(COD)(IMes)Cl (A) and 0.1 M 15N-NA with 5 mM Ir(COD)(IMes)Cl (B) in methanol-d4 hyperpolarized by SLIC-SABRE with 35 sccm pH2 flow rate at 9.4 T. 2D images were acquired using SLIC-SABRE hyperpolarization and FLASH spatial encoding and acquisition elements (C). Repetition time (TR) was 3.1 ms, echo time time (TE) was 1 ms. Experiments were carried out at room temperature. The number of SLIC-SABRE pumping cycles, n, was 10 and no signal averaging was employed. Acquisition spectral width (SW) was 10 kHz, spatial resolution was 0.15×2.4 mm2/pixel (A) and 0.3×4.8 mm2/pixel (B). Field of view was 1.9×1.9 cm2 (A) and 3.8×3.8 cm2 (B), Acquisition matrix was 128×8, it was were zero-filled to matrix size of 128×128 (A) and 256×256 (B) before image reconstruction.

Specifically, we hyperpolarized 15N-pyridine (15N-Py) and 1-15N-nicotinamide (15N-NA) via SLIC-SABRE at the high field of an MRI scanner. The parameters for the SLIC-SABRE of 15N-Py were similar to those optimized and reported before: amplitude of RF-pulse, ν1 = 5 Hz, offset from the center of bound 15N-Py resonance, Δrf 17 Hz and duration of continuous wave (CW) RF-pulse, tcw = 1.17 s.[47] For 15N-NA, we used the same parameters of SLIC-SABRE (ν1, Δrf, tcw) because when attached to active SABRE-complex it has similar J-coupling constants with hydride protons coming from pH2. Additionally, we optimized the number of pumping cycles and pH2 flow rate, as described previously[47] (see Fig. S2, SI). All necessary parameters of the experiments are listed in the Tab. S4 (SI).

The resulting polarization enhancement factors for free substrate were: ε15N ~ 1,374 for 15N-Py (P ≈ 0.3 %) and ε15N ~ 834 (P ≈ 0.2 %) for 15N-NA at 7 T (Fig. 1). Optimization of the SLIC-SABRE pulse sequence parameters and the calculation of the signal enhancement are given in SI. In the Ref.[45] the time period free from RF excitation to refresh system with pH2 was used, but omitted in this paper. Introduction of such stage can potentially increase the level of hyperpolarization.

Figure 1.

Figure 1.

15N NMR spectra of 15N-Py (A) and 15N-NA (B) hyperpolarized by SLIC-SABRE. Strongly enhanced signals of free and catalyst-bound substrate were observed, enhanced by ε15N ~ 1,374 for 15N-Py and ε15N ~ 834 for 15N-NA (see Fig. S1, SI). A pH2 pressure of 3.4 bar and a flow rate of 80 sccm were used. The experiments were carried out at room temperature. Two different samples were used: 0.1 M 15N-Py and 5 mM Ir(IMes) methanol-d4 solution (A) and 0.1 M 15N-NA and 5 mM Ir(IMes) methanol-d4 solution (B).

The MRI sequence with SABRE polarization consists of the following steps: (i) preparation of hyperpolarization with SLIC-SABRE (this stage can be repeated n times to gain the maximal signal enhancement); (ii) excitation of 15N signal with hard 15N RF pulse; (iii) space encoding; (iv) acquisition of 15N signal. Two different space encoding MRI approaches were used: Single Point Imaging and Fast Low Angle SHot (compare Fig. 2,C and Fig. 3,C).

15N-Single-point MRI enhanced by SLIC-SABRE.

High-resolution, 2D Single Point Imaging (SPI) was realized by using two spatial encoding gradients Gx and Gy without slice selection (Fig. 2,C). Each point of k-space was acquired consequently after the SLIC-SABRE pulse sequence, a 90° excitation pulse and two spatial encoding gradients. In total, 16×16=256 points were acquired, resulting in a high native spatial resolution of 565×565 μm2/pixel. It means that the experiments were repeated 256 times with constant hyperpolarization production. Here we took advantage of SABRE method that allows, unlike DNP, fast and continuous production of hyperpolarization. The gained resolution was sufficient to image the thin, 1/16 inches 1.6 mm capillary supplying pH2 to the NMR tube (Fig. 2). Note that the fine details were resolved despite the fact that pH2 was continuously supplied, which induces convection in the liquid sample. In the context of biomedical applications, however, the scan times of 5.5 minutes (Py) or 27 minutes (NA) are impractical. Moreover, 15N polarization had to be re-created for each point of k-space, which makes the method inherently slow.

15N-FLASH MRI enhanced by SLIC-SABRE.

Using a gradient echo pulse sequence such as Fast Low Angle Shot (FLASH) allows one to decrease the scan time by orders of magnitude. Here, an entire k-space was read out after one SLIC-SABRE block (Fig. 3,C). This is advantageous, because in biomedical conditions, it would be impossible to re-hyperpolarize an injected HP bolus for every excitation, as was done for SPI.

In this setting, the hyperpolarization by SLIC-SABRE took 13 s and the FLASH MRI less than 1 s (repetition time 3.1 ms, echo time 1 ms, 8 phase encoding steps, 128 readout points, Cartesian encoding). There was a delay of approximately 2–4 s between SLIC-SABRE and MRI due to hardware limitations while switching between two pulse sequences. We do not expect significant polarization losses during this delay (see HP decay kinetics in Fig. S3, SI). Note that the whole k-space was acquired after only one implementation of SLIC-SABRE.

As a result, 15N images (Fig. 3) were obtained using a 128×8 matrix that provide a spatial resolution of 0.15×2.4 mm2/pixel (15N-Py) and 0.3×4.8 mm2/pixel (15N-NA). For representation, the k-space data sets were zero-filled to 128×128 and 256×256 for 15N-Py and 15N-NA, respectively.

Conclusion.

The presented approach allowed us to hyperpolarize and image 15N biomolecules inside an MRI instrument, in situ, by SLIC-SABRE in less than a minute. The HP was continuously renewed inside the MRI scanner, which provides certain advantages in the context of biomedical applications.[48] The HP was strong enough to allow subsecond 15N MRI of two 15N-labeled biomolecules: 15N-Py and 15N-NA (vitamin B3). No external polarizer or sample transfer to an MRI scanner are required.

SLIC-SABRE was introduced as an efficient way to transfer polarization from pH2 to a 15N substrate. Here, we obtained 1,374- and 834-fold signal enhancements for 15N-Py and 15N-NA, respectively. Although the polarizations are moderate the enhancements are quite significant and sufficient for fast MRI. We expect that future advances in SLIC-SABRE or related methods will increase the polarization further.

While in these studies organic solvents were used and the catalyst was not removed before imaging, recent advances in filtering,[7,18] heterogeneous catalysis [49] and 15N SABRE-SHEATH in aqueous medium[36] bode well for a future in vivo translation of the presented approach. The 15N sites can retain HP state for tens of minutes, but their detection sensitivity is approximately two orders of magnitude lower than that of protons. This shortcoming can be mitigated by transferring polarization from 15N to J-coupled 1H nuclei and subsequent 1H imaging. Various schemes have been designed for this indirect readout and have already been demonstrated in vivo.[5053]

This work is the first demonstration of hyperpolarized, heteronuclear MRI that was enhanced by SLIC-SABRE rather than by spontaneous polarization transfer. This method can be extended to other heteronuclei such as 13C, 19F, 31P, etc. for biomedical and other applications.

Experimental Section

Iridium N-heterocyclic carbene complexes, Ir(COD)(IMes)Cl (IMes = 1,3-bis(2,4,6-trimethylphenyl)imidazole-2-ylidene, COD = cyclooctadiene) was used as a pre-catalyst to provide SABRE. This complex was prepared from commercially available precursors ([It(COD)Cl]2, abcr GmbH, CAS: 12112-67-3; [IMes]+[BF4], Sigma Aldrich, CAS: 245679-18-9) according to the previously described method.[54,55] Pre-catalyst was activated by bubbling pH2 through the reagent solution in the presence of a substrate during 20 minutes with pH2 flow rate of 20 sccm and 1.7 bar overpressure. Activation was required to convert the pre-catalyst to the active Ir(IMes)(sub)3Cl SABRE-complex.

15N-pyridine and 1-15N-nicotinamide used as SABRE substrates were synthesized according to the procedures described in the literature (for details of synthesis of 15N-pyridine see SI).[56,57] 600 μl methanol-d4 mixtures: 1 M solution of 15N-Py and 50 mM of Ir(COD)(IMes)Cl, 0.1 M solution of 15N-Py and 5 mM of Ir(COD)(IMes)Cl or 0.1 M solution of 15N-NA and 5 mM Ir(COD)(IMes)Cl, were used for MRI experiments. All experiments were carried out using standard 5 mm NMR tubes. pH2 was supplied to the solution through the capillary system equipped with a mass flow controller and back pressure valves (Fig. 4). pH2 was prepared using a commercially available pH2 generator with a conversion temperature of 38 K that provides ~90% enrichment of the para fraction (Bruker, BPHG90).

Figure 4.

Figure 4.

Scheme of the HF-SABRE MR setup. pH2 was supplied to the sample solution placed inside the spectrometer trough the capillary system. The gas system contained mass flow controller and back pressure valves

MR images were acquired with a 400 MHz (B0 = 9.4 T) microimaging instrument (Bruker, Avance III) equipped with a two-channel probe (1H, 15N) and maximal gradient strength of 150 G/cm. The SLIC pulse sequence[58] was used to transfer nuclear spin order from pH2 to 15N in the strong magnetic field.[45,58] NMR spectra were obtained on a 300 MHz (B0 = 7 T) NMR spectrometer (Bruker, Avance).

15N-Single-point MRI enhanced by SLIC-SABRE.

Parahydrogen was delivered to the solution at 1.7 bar and 7 sccm flow rate during SLIC-SABRE and MRI. For SPI, two phase encoding gradients (Fig. 2, C) were applied after non-selective 90° excitation, and each point of k-space was acquired separately after SLIC-SABRE (a total of 16×16). Phase encoding gradients had 45% strength of maximal value and 300 μs duration. 1 or 5 SLIC-SABRE cycles of ca. 1.2 s each were applied for HP of 15N-Py and 15N-NA, respectively.

15N-FLASH MRI enhanced by SLIC-SABRE.

For both substrates, SLIC-SABRE (ca. 1.2 s each) was repeated 10 times, resulting in a total duration of 13 s. At the beginning, pH2 was flushed through the solution with a flow rate of 35 sccm and 3.5 bar pressure. Importantly, the flow of pH2 was stopped 4–6 s before the onset of the MRI (11 s after the onset of SLIC) to reduce magnetic field inhomogeneities and fast convection caused by the bubbles. There was a delay of approximately 2–4 s between SLIC-SABRE and MRI due to hardware limitations. Duration of the FLASH was less than a second, TR was 3.1 ms, TE was 1 ms. Phase encoding gradient had 8% strength of maximal value and 400 μs duration, readout gradient had 4% strength and 2.1 ms duration. The flip angle was 30°. No k-space filter was applied.

Supplementary Material

SI

Acknowledgements

A.S., N.V.C., and K.V.K. thank the Russian Science Foundation (grant #17-73-20030) for the support 15N MR imaging experiments of pyridine and nicotinamide. I.V.S and I.V.K thank RFBR and DFG (grant # 19-53-12013) for the support of synthesis of 15N-labeled compounds and Ministry of Science and Higher Education of the RF (АААА-А16-116121510087-5) for access to NMR equipment. E.Y.C thanks the following funding support: NSF under grant CHE-1836308, NIH 1R21EB020323 and R21CA220137, DOD CDMRP W81XWH-12-1-0159/BC112431. A. N. P. and J.-B. H. acknowledge support by the DFG in the Emmy Noether Program (HO 4604/2–1), the Research Training Circle Materials for Brain (GRK 2154), DFG - RFBR grant (HO 4604/3–1, № 19-53-12013), the cluster of excellence “Inflammation at Interfaces” (EXC 306) and precision medicine in inflammation (PMI 1267). Kiel University and the Medical Faculty are acknowledged for supporting the Molecular Imaging North Competence Center (MOIN CC) as a core facility for imaging in vivo. MOIN CC was founded by a grant of the European Regional Development Fund (ERDF) and the Zukunftsprogramm Wirtschaft of Schleswig-Holstein (Project no. 122-09-053).

Footnotes

Supporting information for this article is given via a link at the end of the document.

References

  • [1].Adams RW, Aguilar JA, Atkinson KD, Cowley MJ, Elliott PIP, Duckett SB, Green GGR, Khazal IG, Lopez-Serrano J, Williamson DC, Science (80-. ). 2009, 323, 1708–1711. [DOI] [PubMed] [Google Scholar]
  • [2].Bowers CR, Weitekamp DP, Phys. Rev. Lett 1986, 57, 2645–2648. [DOI] [PubMed] [Google Scholar]
  • [3].Nikolaou P, Goodson BM, Chekmenev EY, Chem. - A Eur. J 2015, 21, 3156–3166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Kovtunov KV, Pokochueva EV, Salnikov OG, Cousin SF, Kurzbach D, Vuichoud B, Jannin S, Chekmenev EY, Goodson BM, Barskiy DA, et al. , Chem. - An Asian J. 2018, 13, 1857–1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Barskiy DA, Pravdivtsev AN, Ivanov KL, Kovtunov KV, Koptyug IV, Phys. Chem. Chem. Phys 2016, 18, 89–93. [DOI] [PubMed] [Google Scholar]
  • [6].Hövener J-B, Pravdivtsev AN, Kidd B, Bowers CR, Glöggler S, V Kovtunov K, Plaumann M, Katz-Brull R, Buckenmaier K, Jerschow A, et al. , Angew. Chemie Int. Ed 2018, 57, 11140–11162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Hövener JB, Schwaderlapp N, Borowiak R, Lickert T, Duckett SB, Mewis RE, Adams RW, Burns MJ, Highton LAR, Green GGR, et al. , Anal. Chem 2014, 86, 1767–1774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Carr HY, Phys. Rev 1958, 112, 1693–1701. [Google Scholar]
  • [9].Hövener J-B, Schwaderlapp N, Lickert T, Duckett SB, Mewis RE, Highton LAR, Kenny SM, Green GGR, Leibfritz D, Korvink JG, et al. , Nat. Commun 2013, 4, 2946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Štěpánek P, Sanchez-Perez C, Telkki V-V, Zhivonitko V, Kantola AM, J. Magn. Reson 2019, DOI 10.1016/j.jmr.2019.01.003. [DOI] [PubMed] [Google Scholar]
  • [11].Barskiy DA, Kovtunov KV, Koptyug IV, He P, Groome KA, Best QA, Shi F, Goodson BM, Shchepin RV, Truong ML, et al. , ChemPhysChem 2014, 15, 4100–4107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Sarkar R, Comment A, Vasos PR, Jannin S, Gruetter R, Bodenhausen G, Hall H, Kirik D, Denisov VP, J. Am. Chem. Soc 2009, 131, 16014–16015. [DOI] [PubMed] [Google Scholar]
  • [13].Nonaka H, Hata R, Doura T, Nishihara T, Kumagai K, Akakabe M, Tsuda M, Ichikawa K, Sando S, Nat. Commun 2013, 4, 2411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Bales LB, Kovtunov KV, Barskiy DA, Shchepin RV, Coffey AM, Kovtunova LM, Bukhtiyarov AV, Feldman MA, Bukhtiyarov VI, Chekmenev EY, et al. , J. Phys. Chem. C 2017, 121, 15304–15309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Cudalbu C, Comment A, Kurdzesau F, Heeswijk RB, Uffmann K, Jannin S, Denisov V, Kirike D, Gruetter R, Phys. Chem. Chem. Phys 2010, 12, 5818–5823. [DOI] [PubMed] [Google Scholar]
  • [16].Theis T, Ortiz GX, Logan AWJ, Claytor KE, Feng Y, Huhn WP, Blum V, Malcolmson SJ, Chekmenev EY, Wang Q, et al. , Sci. Adv 2016, 2, e1501438–e1501438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].McCormick J, Korchak S, Mamone S, Ertas YN, Liu Z, Verlinsky L, Wagner S, Glöggler S, Bouchard LS, Angew. Chemie - Int. Ed 2018, 57, 10692–10696. [DOI] [PubMed] [Google Scholar]
  • [18].Kidd BE, Gesiorski JL, Gemeinhardt ME, Shchepin RV, Kovtunov KV, Koptyug IV, Chekmenev EY, Goodson BM, J. Phys. Chem. C 2018, 122, 16848–16852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Barskiy DA, Ke LA, Li X, Stevenson V, Widarman N, Zhang H, Truxal A, Pines A, J. Phys. Chem. Lett 2018, 9, 2721–2724. [DOI] [PubMed] [Google Scholar]
  • [20].Kovtunov KV, Pokochueva EV, Salnikov OG, Cousin SF, Kurzbach D, Vuichoud B, Jannin S, Chekmenev EY, Goodson BM, Barskiy DA, et al. , Chem. - An Asian J 2018, 13, 1857–1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Jannin S, Bornet A, Melzi R, Bodenhausen G, Chem. Phys. Lett 2012, 549, 99–102. [Google Scholar]
  • [22].Milani J, Vuichoud B, Bornet A, Melzi R, Jannin S, Bodenhausen G, Rev. Sci. Instrum 2017, 88, 15109. [DOI] [PubMed] [Google Scholar]
  • [23].Mewis RE, Green RA, Cockett MCR, Cowley MJ, Duckett SB, Green GGR, John RO, Rayner PJ, Williamson DC, J. Phys. Chem. B 2015, 119, 1416–1424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].V Shchepin R, Barskiy DA, Coffey AM, Theis T, Shi F, Warren WS, Goodson BM, Chekmenev EY, ACS Sensors 2016, 1, 640–644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Chukanov NV, Salnikov OG, V Shchepin R, Svyatova A, Kovtunov KV, Koptyug IV, Chekmenev EY, J. Phys. Chem. C 2018, 122, 23002–23010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Shchepin RV, Goodson BM, Theis T, Warren WS, Chekmenev EY, ChemPhysChem 2017, 18, 1961–1965. [DOI] [PubMed] [Google Scholar]
  • [27].Burns MJ, Rayner PJ, Green GGR, Highton LAR, Mewis RE, Duckett SB, J. Phys. Chem. B 2015, 119, 5020–5027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Zhivonitko VV, Skovpin IV, Koptyug IV, Chem. Commun 2015, 51, 2506–2509. [DOI] [PubMed] [Google Scholar]
  • [29].Jiang W, Lumata L, Chen W, Zhang S, Kovacs Z, Sherry AD, Khemtong C, Sci. Rep 2015, 5, 9104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Gabellieri C, Reynolds S, Lavie A, Payne GS, Leach MO, Eykyn TR, J. Am. Chem. Soc 2008, 130, 4598–4599. [DOI] [PubMed] [Google Scholar]
  • [31].Cudalbu C, Comment A, Kurdzesau F, van Heeswijk RB, Uffmann K, Jannin S, Denisov V, Kirik D, Gruetter R, Phys. Chem. Chem. Phys 2010, 12, 5818. [DOI] [PubMed] [Google Scholar]
  • [32].Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PEZ, Harzstark AL, Ferrone M, van Criekinge M, Chang JW, Bok R, Park I, et al. , Sci. Transl. Med 2013, 5, 198ra108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Truong ML, Theis T, Coffey AM, Shchepin RV, Waddell KW, Shi F, Goodson BM, Warren WS, Chekmenev EY, J. Phys. Chem. C 2015, 119, 8786–8797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Theis T, Truong ML, Coffey AM, Shchepin RV, Waddell KW, Shi F, Goodson BM, Warren WS, Chekmenev EY, J. Am. Chem. Soc 2015, 137, 1404–1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Barskiy DA, Shchepin RV, Coffey AM, Theis T, Warren WS, Goodson BM, Chekmenev EY, J. Am. Chem. Soc 2016, 138, 8080–8083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Colell JFP, Emondts M, Logan AWJ, Shen K, Bae J, Shchepin RV, Ortiz GX, Spannring P, Wang Q, Malcolmson SJ, et al. , J. Am. Chem. Soc 2017, 139, 7761–7767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Kiryutin AS, Yurkovskaya AV, Zimmermann H, Vieth H-M, Ivanov KL, Magn. Reson. Chem 2018, 56, 651–662. [DOI] [PubMed] [Google Scholar]
  • [38].Barskiy DA, Kovtunov KV, Koptyug IV, He P, Groome K. a., Best Q. a., Shi F, Goodson BM, Shchepin RV, Coffey AM, et al. , J. Am. Chem. Soc 2014, 136, 3322–3325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Pravdivtsev AN, V Yurkovskaya A, Petrov PA, Vieth H, Appl. Magn. Reson 2016, 47, 711–725. [Google Scholar]
  • [40].V Kovtunov K, Kidd BE, Salnikov OG, Bales LB, Gemeinhardt ME, Gesiorski J, V Shchepin R, Chekmenev EY, Goodson BM, V Koptyug I, J. Phys. Chem. C 2017, 121, 25994–25999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Roy SS, Stevanato G, Rayner PJ, Duckett SB, J. Magn. Reson 2017, 285, 55–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Pravdivtsev AN, Yurkovskaya AV, Zimmermann H, Vieth H-M, Ivanov KL, Chem. Phys. Lett 2016, 661, 77–82. [Google Scholar]
  • [43].Theis T, Truong M, Coffey AM, Chekmenev EY, Warren WS, J. Magn. Reson 2014, 248, 23–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Pravdivtsev AN, V Yurkovskaya A, Zimmermann H, Vieth H, Ivanov KL, RSC Adv. 2015, 5, 63615–63623. [Google Scholar]
  • [45].Knecht S, Kiryutin AS, Yurkovskaya AV, Ivanov KL, Mol. Phys 2018, 0, 1–10. [Google Scholar]
  • [46].Theis T, Ariyasingha NM, Shchepin RV, Lindale JR, Warren WS, Chekmenev EY, J. Phys. Chem. Lett 2018, 9, 6136–6142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Pravdivtsev AN, Skovpin IV, Svyatova AI, V Chukanov N, Kovtunova LM, Bukhtiyarov VI, Chekmenev EY, V Kovtunov K, V Koptyug I, Hövener J-B, J. Phys. Chem. A 2018, 122, 9107–9114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Schmidt AB, Berner S, Braig M, Zimmermann M, Hennig J, von Elverfeldt D, Hövener J-B, PLoS One 2018, 13, e0200141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Kovtunov KV, Kovtunova LM, Gemeinhardt ME, Bukhtiyarov AV, Gesiorski J, Bukhtiyarov VI, Chekmenev EY, Koptyug IV, Goodson BM, Angew. Chemie - Int. Ed 2017, 56, 10433–10437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].Truong ML, Coffey AM, Shchepin RV, Waddell KW, Chekmenev EY, Contrast Media Mol. Imaging 2014, 9, 333–341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Wang J, Kreis F, Wright AJ, Hesketh RL, Levitt MH, Brindle KM, Magn. Reson. Med 2018, 79, 741–747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Norton VA, Weitekamp DP, J. Chem. Phys 2011, 135, 141107. [DOI] [PubMed] [Google Scholar]
  • [53].Chekmenev EY, Norton VA, Weitekamp DP, Bhattacharya P, J. Am. Chem. Soc 2009, 131, 3164–3165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Cowley MJ, Adams RW, Atkinson KD, Cockett MC, Duckett SB, Green GG, Lohman JA, Kerssebaum R, Kilgour D, Mewis RE, J. Am. Chem. Soc 2011, 133, 6134–6137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Vazquez-serrano LD, Owens BT, Buriak JM, 2006, 359, 2786–2797. [Google Scholar]
  • [56].V Shchepin R, Barskiy DA, Mikhaylov DM, Chekmenev EY, Bioconj. Chem 2016, 27, 878–882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [57].Whaley TW, Ott DG, J. Labelled Compd 1974, 10, 283–286. [Google Scholar]
  • [58].DeVience SJ, Walsworth RL, Rosen MS, Phys. Rev. Lett 2013, 111, 173002. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES